Tenpoint, Visus merge in effort to push presbyopia-correcting eye drop over FDA finish line

Published: 12/12/2024

Tenpoint, Visus merge in effort to push presbyopia-correcting eye drop over FDA finish line

tags

Latest News

NEWS 01.14.2026

Magnetic stimulation advances heart organoids for future therapies – Drug Target Review

NEWS 01.14.2026

BioPlus announced on the 14th that it appointed Dr. Han In-seok as vice chairman and general represe.. – 매일경제

NEWS 01.14.2026

Creative Medical (CELZ) Reports Promising Interim Data for Chron – GuruFocus

NEWS 01.14.2026

Data-driven visualization of silica-based nanobiomaterial dynamics for tissue regeneration – Nature